Startups
Since 1925 we have been the name behind the high performance ingredients and technologies in some of the biggest, most successful brands in the world: creating, making and selling speciality chemicals that are relied on by industries and consumers everywhere.
We are a FTSE 100 company with more than 4,300 employees working together globally as one team across manufacturing sites and offices in 37 countries.
Our flexible structure allows us to focus on developing and delivering innovative, sustainable ingredients that our customers can build on in: Personal Care, Health Care, Crop Care, Polymer Additives, Energy Technologies, Coatings & Polymers, Home Care and Industrial Specialities.
We are a FTSE 100 company with more than 4,300 employees working together globally as one team across manufacturing sites and offices in 37 countries.
Our flexible structure allows us to focus on developing and delivering innovative, sustainable ingredients that our customers can build on in: Personal Care, Health Care, Crop Care, Polymer Additives, Energy Technologies, Coatings & Polymers, Home Care and Industrial Specialities.
Overview
Location
United Kingdom, England, Goole
Employees
5001-10000
Total raised
$75M
Founded date
1925
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 26
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 15, 2026 | Pharmaceutical Excipients Market Trends: Innovation in Drug Delivery Accelerates Industry Growth | The Pharmaceutical Excipients Market size was valued at USD 10.68 Billion in 2024 and the total Pharmaceutical Excipients revenue is expected to grow at a CAGR of 6.8% from 2025 to 2032, reaching nearly USD 18.07 Billion. Pharmaceutical Exc... |
| May 28, 2026 | Amyris CEO on the post-bankruptcy re-boot: ‘We’re a drastically different company’ | Two years after emerging from bankruptcy, biomanufacturing specialist Amyris is not yet profitable, but is a “drastically different company” with a burn rate a “fraction of what it was” thanks to tighter operational controls, stronger cash ... |
| Mar 3, 2026 | in-cosmetics Global 2026 to serve a taste of tomorrow's beauty in Paris | PARIS, March 3, 2026 /PRNewswire/ -- in-cosmetics Global 2026, the world's leading event for personal care ingredients, returns to Paris from 14–16 April, offering the global beauty industry a crucial opportunity to stay ahead in an in... |
| Feb 25, 2026 | FTSE 100 Live: Index hits record as HSBC, St James’s stock rally | Good morning and welcome back to the City AM liveblog. There’s a number of factors weighing on global markets at the moment, and yet the FTSE 100 was able to close Tuesday’s session unscathed. It came despite President Donald Trump’s new 10... |
| May 28, 2025 | Exclusive Global 20 Seats, China's Sole One! KT-939 Was Successfully Selected for 2025 NYSCC Inspiration Hive Zone | SUZHOU, China, May 28, 2025 /PRNewswire/ -- In the newly announced entry list of the Inspiration Hive zone at the 2025 New York Society of Cosmetic Chemists (NYSCC) exhibition, Kintor's innovative ingredient KT-939 has been selected as... |
| Feb 25, 2025 | Croda International’s profit slumps as sales take a hit | |
| Sep 17, 2024 | The Rise of Vegan Cosmetics: A Green Revolution in Beauty | The beauty industry is undergoing a seismic shift. The spotlight is on vegan cosmetics and personal care products. This market, valued at $10.92 billion in 2024, is projected to double by 2034, reaching $21.79 billion. The growth is not jus... |
| Sep 16, 2024 | $21.79 Bn Vegan Cosmetics and Personal Care Ingredients Markets with L’Oreal, Lush Retail, Pacifica Beauty, and CoverFX Dominating – Global and Regional Analysis and Forecast, 2024-2034 – ResearchAndMarkets.com | DUBLIN–(BUSINESS WIRE)–The “Vegan Cosmetics and Personal Care Ingredients Market – A Global and Regional Analysis: Focus on End-use, Product, Ingredients, Packaging, Price Point, Distribution Channel and Region – Analysis and Forecast, 2024... |
| Feb 13, 2024 | Sodium Lauroyl Sarcosinate Market: Projecting a USD 274.8 Million Valuation by 2030, Led by BASF and Croda | The global sodium lauroyl sarcosinate market is projected to reach USD 274.8 million by 2030, with a CAGR of 4.8% from 2023 to 2030. Europe dominates the global sodium lauroyl sarcosinate market due to robust personal care and cosmetic indu... |
Show more
Reviews 0
FAQ about Croda
When was Croda founded?
Croda was founded in 1925.
How much funding has Croda raised?
Croda has raised $75M in total across 1 funding round.
What has the press written about Croda?
Parsers VC has collected 26 articles mentioning Croda, among them “Pharmaceutical Excipients Market Trends: Innovation in Drug Delivery Accelerates Industry Growth” (Jul 15, 2026) and “Amyris CEO on the post-bankruptcy re-boot: ‘We’re a drastically different company’” (May 28, 2026).
Is Croda still active?
Yes, Croda is active; its latest activity on Parsers VC dates from Oct 29, 2026.